CERS News and Press, Cerus Corporation

Cerus Corporation (Nasdaq: CERS) announced today a company-sponsored lunch symposium and a selection of abstracts at the International Society of Blood Transfusion (ISBT) 39 th International ISBT Congress, taking place in Kuala Lumpur, Malaysia, from June 20 through June 24, 2026. Transfusion...

Refinancing extends maturity and lowers cost of capital Enhances financial flexibility and positions Cerus to drive sustainable growth Anticipated annual cash interest expense savings of up to $3.5 million Cerus Corporation (Nasdaq: CERS) announced today the closing of...

2026-05-10 07:51:01 ET ... Read the full article on Seeking Alpha For further details see: Cerus Corporation: Strong Q1 Results Validate The Turnaround Thesis

2026-05-01 04:22:41 ET More on Cerus Cerus Corporation (CERS) Q1 2026 Earnings Call Transcript Cerus' Record 2025 Sets It Up For Another Leg Higher Cerus Corporation (CERS) Q4 2025 Earnings Call Transcript Cerus GAAP EPS of -$0.01 beats by $0.03, revenue of $...

2026-05-01 04:21:34 ET Cerus Corporation (CERS) Q1 2026 Earnings Call April 30, 2026 4:30 PM EDT Company Participants Timothy Lee - Head of Investor Relation Vivek Jayaraman - Chief Operating Officer Kevin Green - VP of Finance & CFO William Greenman - Pr...

2026-04-30 19:26:29 ET Image source: The Motley Fool. Thursday, April 30, 2026 at 4:30 p.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-04-30 16:09:07 ET More on Cerus Cerus' Record 2025 Sets It Up For Another Leg Higher Cerus Corporation (CERS) Q4 2025 Earnings Call Transcript Cerus appoints Vivek Jayaraman as chief executive officer Cerus GAAP EPS of -$0.01, revenue of $64.6M S...

First Quarter 2026 Total Revenue of $59.9 million, Up 23% Over Prior Year; First Quarter 2026 Product Revenue of $53.7 million, Up 24% Over Prior Year Raising Full Year Product Revenue Guidance Range to $227 million - $231 million, reflecting 10% to 12% year-over-year increase ...

2026-04-29 17:35:54 ET More on Cerus Cerus' Record 2025 Sets It Up For Another Leg Higher Cerus Corporation (CERS) Q4 2025 Earnings Call Transcript Cerus appoints Vivek Jayaraman as chief executive officer Cerus GAAP EPS of -$0.01, revenue of $64.6M S...

Cerus Corporation (Nasdaq: CERS) announced today the signing of a new, four-year supply agreement with Établissement Français du Sang (EFS), the French Blood Establishment, for the INTERCEPT Blood System. The agreement covers the INTERCEPT Blood System for platelets and plasma as well a...